Acute systemic DNA damage in youth does not impair immune defense with aging
Name:
Pugh_et_al-2016-Aging_Cell.pdf
Size:
664.3Kb
Format:
PDF
Description:
Final Published Version
Author
Pugh, Jason L.Foster, Sarah A.
Sukhina, Alona S.
Petravic, Janka
Uhrlaub, Jennifer L.
Padilla-Torres, Jose
Hayashi, Tomonori
Nakachi, Kei
Smithey, Megan J.
Nikolich-Žugich, Janko
Affiliation
Univ Arizona, Coll Med, Dept ImmunobiolUniv Arizona, Coll Med, Arizona Ctr Aging
Univ Arizona, Grad Interdisciplinary Program Genet
Univ Arizona, Inst BIO5
Univ Arizona, Coll Med, Translat Neurotrauma Res Program, Barrow Neurol Inst,Phoenix Childrens Hosp,Dept Ch
Issue Date
2016-08
Metadata
Show full item recordPublisher
WILEY-BLACKWELLCitation
Acute systemic DNA damage in youth does not impair immune defense with aging 2016, 15 (4):686 Aging CellJournal
Aging CellRights
© 2016 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Aging-related decline in immunity is believed to be the main driver behind decreased vaccine efficacy and reduced resistance to infections in older adults. Unrepaired DNA damage is known to precipitate cellular senescence, which was hypothesized to be the underlying cause of certain age-related phenotypes. Consistent with this, some hallmarks of immune aging were more prevalent in individuals exposed to whole-body irradiation (WBI), which leaves no anatomical repository of undamaged hematopoietic cells. To decisively test whether and to what extent WBI in youth will leave a mark on the immune system as it ages, we exposed young male C57BL/ 6 mice to sublethal WBI (0.5-4 Gy), mimicking human survivor exposure during nuclear catastrophe. We followed lymphocyte homeostasis thorough the lifespan, response to vaccination, and ability to resist lethal viral challenge in the old age. None of the irradiated groups showed significant differences compared with mock-irradiated (0 Gy) animals for the parameters measured. Even the mice that received the highest dose of sublethal WBI in youth (4 Gy) exhibited equilibrated lymphocyte homeostasis, robust T-and B-cell responses to live attenuated West Nile virus (WNV) vaccine and full survival following vaccination upon lethal WNV challenge. Therefore, a single dose of nonlethal WBI in youth, resulting in widespread DNA damage and repopulation stress in hematopoietic cells, leaves no significant trace of increased immune aging in a lethal vaccine challenge model.ISSN
14749718PubMed ID
27072188Version
Final published versionSponsors
USPHS contract from the National Institute of Allergy and Infectious Diseases [HHSN272200900059C]Additional Links
http://doi.wiley.com/10.1111/acel.12478ae974a485f413a2113503eed53cd6c53
10.1111/acel.12478
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © 2016 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License.
Related articles
- Lifelong cytomegalovirus and early-LIFE irradiation synergistically potentiate age-related defects in response to vaccination and infection.
- Authors: Pugh JL, Coplen CP, Sukhina AS, Uhrlaub JL, Padilla-Torres J, Hayashi T, Nikolich-Žugich J
- Issue date: 2022 Jul
- Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitis.
- Authors: Uhrlaub JL, Brien JD, Widman DG, Mason PW, Nikolich-Zugich J
- Issue date: 2011 Apr 1
- A West Nile virus CD4 T cell epitope improves the immunogenicity of dengue virus serotype 2 vaccines.
- Authors: Hughes HR, Crill WD, Davis BS, Chang GJ
- Issue date: 2012 Mar 15
- Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
- Authors: Long MT, Gibbs EP, Mellencamp MW, Bowen RA, Seino KK, Zhang S, Beachboard SE, Humphrey PP
- Issue date: 2007 Nov
- A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.
- Authors: Schneeweiss A, Chabierski S, Salomo M, Delaroque N, Al-Robaiy S, Grunwald T, Bürki K, Liebert UG, Ulbert S
- Issue date: 2011 Aug 26

